Yarrow Bioscience, Inc. SEC filings YARW

Yarrow Bioscience, Inc. has 682 filings in SEC EDGAR's recent list, going back to Jan 7, 2013. Its latest annual report, Form ARS, was filed on Jun 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on December 31.

Yarrow Bioscience, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Sep 14, 2026 Sep 10, 2026
424B5 Prospectus supplement Sep 11, 2026 —
424B5 Prospectus supplement Sep 11, 2026 —
8-K Current report
Other events
Sep 10, 2026 Sep 10, 2026
EFFECT Filing Aug 19, 2026 —
POS AM Filing Aug 14, 2026 —
8-K/A Amended current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Jul 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 30, 2026 Jul 29, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Jul 28, 2026 Jul 24, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 21, 2026 Jul 21, 2026
8-K Current report
Shareholder vote results
Jul 20, 2026 Jul 16, 2026
425 Filing Jul 14, 2026 —
8-K Current report
Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
425 Filing Jul 10, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jul 10, 2026 Jul 10, 2026
ARS Annual report to shareholders Jun 16, 2026 Dec 31, 2025
EFFECT Filing Jun 15, 2026 —
424B3 Prospectus Jun 15, 2026 —
S-4/A Filing Jun 3, 2026 —
8-K Current report
Regulation FD disclosure
May 21, 2026 May 21, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
S-4/A Filing Apr 28, 2026 —
S-4 Registration for a merger or exchange Mar 31, 2026 —
8-K Current report
Listing notice
Mar 11, 2026 Mar 11, 2026
10-K Annual report Feb 27, 2026 Dec 31, 2025
DRS Filing Jan 30, 2026 —
425 Filing Jan 30, 2026 —
8-K Current report
Material agreement
Jan 30, 2026 Jan 30, 2026
425 Filing Dec 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
Dec 17, 2025 Dec 17, 2025
8-K Current report
Shareholder vote results
Dec 12, 2025 Dec 12, 2025
ARS Annual report to shareholders Nov 12, 2025 Dec 31, 2024
DEF 14A Proxy statement Nov 12, 2025 Dec 12, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Listing notice
Sep 12, 2025 Sep 11, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 14, 2025 Aug 11, 2025
8-K Current report
Results of operations, Other events
Jul 30, 2025 Jul 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Dec 23, 2024 Dec 23, 2024
S-8 Employee stock plan registration Dec 19, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 12, 2024 Dec 12, 2024
ARS Annual report to shareholders Nov 12, 2024 Dec 31, 2023
DEF 14A Proxy statement Nov 12, 2024 Dec 12, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Sep 12, 2024 Sep 12, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
EFFECT Filing Mar 14, 2024 —
CORRESP Letter to the SEC Mar 12, 2024 —
UPLOAD Letter from the SEC Mar 6, 2024 —
S-3 Shelf registration Mar 1, 2024 —
S-8 Employee stock plan registration Mar 1, 2024 —
10-K Annual report Mar 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 3, 2024 Dec 29, 2023
S-8 Employee stock plan registration Dec 13, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 13, 2023 Dec 11, 2023
EFFECT Filing Nov 22, 2023 —
424B3 Prospectus Nov 22, 2023 —
CORRESP Letter to the SEC Nov 20, 2023 —
UPLOAD Letter from the SEC Nov 17, 2023 —
D Filing Nov 16, 2023 —
S-3 Shelf registration Nov 13, 2023 —
ARS Annual report to shareholders Nov 13, 2023 Dec 31, 2022
DEF 14A Proxy statement Nov 13, 2023 Dec 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Material agreement, Agreement ended, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Oct 30, 2023 Oct 27, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Material agreement, Regulation FD disclosure
May 1, 2023 Apr 28, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Feb 28, 2023 Feb 27, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Feb 10, 2023 Feb 8, 2023
8-K Current report
Bylaw or fiscal year change
Jan 17, 2023 Jan 17, 2023
8-K Current report
Results of operations, Shareholder vote results, Regulation FD disclosure, Other events
Jan 12, 2023 Jan 12, 2023
DEF 14A Proxy statement Nov 25, 2022 Jan 12, 2023
D Filing Nov 18, 2022 —
PRE 14A Preliminary proxy statement Nov 14, 2022 Jan 12, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2022 Nov 10, 2022
8-K Current report
Listing notice, Other events
Aug 30, 2022 Aug 29, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 12, 2022
8-K Current report
Shareholder vote results, Other events
Aug 10, 2022 Aug 10, 2022
DEFA14A Additional proxy material Jul 28, 2022 —
8-K Current report
Regulation FD disclosure
Jul 27, 2022 Jul 27, 2022
DEFA14A Additional proxy material Jul 19, 2022 —
DEFA14A Additional proxy material Jul 7, 2022 —
DEF 14A Proxy statement Jun 17, 2022 Aug 10, 2022
8-K Current report
Material agreement, Other events
Jun 17, 2022 Jun 15, 2022
PRE 14A Preliminary proxy statement Jun 7, 2022 Aug 10, 2022
8-K Current report
Regulation FD disclosure
May 17, 2022 May 17, 2022
424B5 Prospectus supplement May 12, 2022 —
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
8-K Current report
Auditor change, Other events
Apr 7, 2022 Apr 6, 2022
8-K Current report
Other events
Mar 30, 2022 Mar 30, 2022
S-8 Employee stock plan registration Mar 17, 2022 —
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
8-K Current report
Material agreement, Officer or director change
Mar 15, 2022 Mar 15, 2022
424B5 Prospectus supplement Mar 15, 2022 —
8-K Current report
Regulation FD disclosure
Mar 8, 2022 Mar 8, 2022
8-K Current report
Other events
Mar 7, 2022 Mar 7, 2022
8-K Current report
Listing notice
Mar 4, 2022 Feb 28, 2022
8-K Current report
Other events
Jan 19, 2022 Jan 19, 2022
8-K/A Amended current report
Officer or director change
Jan 14, 2022 Jan 12, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Jan 13, 2022 Jan 12, 2022
8-K Current report
Regulation FD disclosure
Jan 5, 2022 Jan 5, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2021 Nov 10, 2021
8-K Current report
Other events
Nov 4, 2021 Nov 4, 2021
8-K Current report
Other events
Oct 26, 2021 Oct 26, 2021
8-K Current report
Other events
Oct 19, 2021 Oct 19, 2021
8-K Current report
Officer or director change
Sep 3, 2021 Sep 2, 2021
8-K Current report
Material agreement
Aug 12, 2021 Aug 12, 2021
424B5 Prospectus supplement Aug 12, 2021 —
8-K Current report
Other events
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Aug 12, 2021 Aug 12, 2021
8-K Current report
Other events
Aug 9, 2021 Aug 9, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jul 19, 2021 Jul 19, 2021
8-K Current report
Other events
Jul 2, 2021 Jun 30, 2021
DEFA14A Additional proxy material Jun 29, 2021 —
DEFA14A Additional proxy material Jun 7, 2021 —
DEF 14A Proxy statement Jun 7, 2021 Jul 19, 2021
8-K Current report
Officer or director change
Jun 7, 2021 Jun 4, 2021
PRE 14A Preliminary proxy statement May 26, 2021 Jul 19, 2021
EFFECT Filing May 14, 2021 —
CORRESP Letter to the SEC May 11, 2021 —
UPLOAD Letter from the SEC May 10, 2021 —
S-3 Shelf registration May 6, 2021 —
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
10-K/A Amended annual report Apr 20, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Mar 30, 2021 Mar 30, 2021
S-8 Employee stock plan registration Mar 4, 2021 —
8-K Current report
Regulation FD disclosure
Mar 4, 2021 Mar 4, 2021
10-K Annual report Mar 4, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
8-K Current report
Regulation FD disclosure
Mar 1, 2021 Mar 1, 2021
8-K Current report
Regulation FD disclosure
Feb 16, 2021 Feb 16, 2021
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Feb 12, 2021 Feb 12, 2021
8-K Current report
Regulation FD disclosure
Feb 11, 2021 Feb 11, 2021
8-K Current report
Material agreement
Jan 28, 2021 Jan 26, 2021
424B5 Prospectus supplement Jan 27, 2021 —
8-K Current report
Results of operations
Jan 26, 2021 Jan 26, 2021
8-K Current report
Regulation FD disclosure
Jan 7, 2021 Jan 7, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Regulation FD disclosure
Oct 7, 2020 Oct 5, 2020
8-K Current report
Regulation FD disclosure
Oct 1, 2020 Oct 1, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 14, 2020 Sep 8, 2020
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Sep 8, 2020 Sep 4, 2020
8-K Current report
Regulation FD disclosure
Sep 2, 2020 Sep 2, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results
Aug 3, 2020 Aug 3, 2020
DEFA14A Additional proxy material Jul 14, 2020 —
DEFA14A Additional proxy material Jun 22, 2020 —
DEF 14A Proxy statement Jun 22, 2020 Aug 3, 2020
PRE 14A Preliminary proxy statement Jun 10, 2020 Aug 3, 2020
8-K Current report
Auditor change
Jun 10, 2020 Jun 9, 2020
8-K Current report
Material agreement
Jun 9, 2020 Jun 4, 2020
424B2 Prospectus Jun 5, 2020 —
424B5 Prospectus supplement Jun 4, 2020 —
8-K Current report
Other events
Jun 2, 2020 Jun 2, 2020
8-K Current report
Other events
Jun 2, 2020 Jun 2, 2020
8-K Current report
Other events
May 29, 2020 May 29, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
8-K/A Amended current report May 7, 2020 Mar 9, 2020
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Apr 23, 2020 Apr 21, 2020
8-K Current report
Officer or director change
Apr 10, 2020 Apr 9, 2020
8-K Current report
Auditor change, Bylaw or fiscal year change, Other events
Apr 6, 2020 Apr 2, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 25, 2020 Mar 19, 2020
8-K Current report
Regulation FD disclosure
Mar 12, 2020 Mar 12, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Change to shareholder rights, Change in control, Officer or director change, Other events
Mar 10, 2020 Mar 9, 2020
S-8 Employee stock plan registration Mar 9, 2020 —
10-K Annual report Mar 3, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 3, 2020 Mar 3, 2020
8-K Current report
Shareholder vote results, Other events
Feb 6, 2020 Feb 6, 2020
425 8-k Feb 6, 2020 —
8-K Current report
Other events
Jan 28, 2020 Jan 21, 2020
425 8-k Jan 28, 2020 —
425 Filing Jan 16, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
YARW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1566044
Former names
VYNE Therapeutics Inc. (until Jul 24, 2026); Menlo Therapeutics Inc. (until Sep 2, 2020); Menlo Therapeutics, Inc. (until Jan 31, 2018); Tigercat Pharma, Inc. (until Jan 7, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.